1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On 04/06/2023 at 1:30pm, Licensing Program Analysts (LPAs) Arielle Pascua, Christina Valerio, and Kimberly Viarella arrived unannounced to this facility to conduct a case management visit. LPAs met with Facility Designated Administrator (FDA), Mark Crowder and explained the purpose of the visit. The purpose of this visit was due to an incident that was learned during the LPAs visit on 04/05/2023.
Current Census was 103. A brief interview with FDA Crowder was conducted. A tour of the facility was conducted.
It was learned during a case management visit conducted on 04/06/2023 that R2 was alleged to have sexually harassed R1. LPA obtained several facility documents to assist in the course of this case management visit.
LPA will return at a later time to finish the case management visit.
No deficiencies cited on this day.
An exit interview was conducted. A copy of this report along with a confidential names list was provided to the facility via email. An electronic response from FDA Crowder confirms receipt of this report. |